NEW YORK, Sept. 18, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sprinklr, Inc. (NYSE: CXM) between March 29, 2023 and June 5, 2024, both dates inclusive (the "Class Period"), of the important October 15, 2024 lead plaintiff deadline. SO WHAT: If you purchased Sprinklr securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO D ...

NEW YORK, Sept. 17, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Orthofix Medical Inc. (NASDAQ: OFIX) between October 11, 2022 and September 12, 2023, both dates inclusive (the "Class Period"), of the important October 21, 2024 lead plaintiff deadline. SO WHAT: If you purchased Orthofix common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee ...

NEW YORK, Sept. 17, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Moderna, Inc. (NASDAQ: MRNA) between January 18, 2023 and June 25, 2024, both dates inclusive (the "Class Period"), of the important October 8, 2024 lead plaintiff deadline. SO WHAT: If you purchased Moderna securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT T ...

NEW YORK, Sept. 17, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of DXC Technology Company (NYSE: DXC) between May 26, 2021 and May 16, 2024, both dates inclusive (the "Class Period"), of the important October 1, 2024 lead plaintiff deadline. SO WHAT: If you purchased DXC common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT ...

● . . | --- | --- | |-----------------------------------------------|-------| | | | | Before Important Deadline in Securities Class | | | Action - LULU | | September 17, 2024 1:10 PM EDT | Source: The Rosen Law Firm PA New York, New York--(Newsfile Corp. - September 17, 2024) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of lululemon athletica inc. (NASDAQ: LULU) between December 7, 2023 and July 24, 2024, both dates inclusive (the "Class Period"), of the importa ...

NEW YORK, Sept. 17, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Outset Medical, Inc. (NASDAQ: OM) between August 1, 2022 and August 7, 2024, both dates inclusive (the "Class Period"), of the important October 28, 2024 lead plaintiff deadline. SO WHAT: If you purchased Outset Medical securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrange ...

NEW YORK, Sept. 17, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DexCom, Inc. (NASDAQ: DXCM) between January 8, 2024 and July 25, 2024, both dates inclusive (the "Class Period"), of the important October 21, 2024 lead plaintiff deadline. SO WHAT: If you purchased DexCom securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO ...

NEW YORK, Sept. 17, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Class A common stock of CrowdStrike Holdings, Inc. (NASDAQ: CRWD) between November 29, 2023 and July 29, 2024, both dates inclusive (the "Class Period"), of the important September 30, 2024 lead plaintiff deadline. SO WHAT: If you purchased CrowdStrike Class A common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs thro ...

NEW YORK, Sept. 17, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sage Therapeutics, Inc. (NASDAQ: SAGE) between April 12, 2021 and July 23, 2024, both dates inclusive (the "Class Period"), of the important October 28, 2024 lead plaintiff deadline. SO WHAT: If you purchased Sage securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. ...

文章核心观点 - 根据诉讼,在2024年2月15日至7月24日期间,Stellantis N.V.(NYSE: STLA)向投资者提供了关于2024年预期收入的重大信息 [3] - 被告人发布了包括减少库存水平、价格改善和产品组合扩展等积极信息,支持其预测2024年调整后营业利润率将达到两位数,以及正的工业自由现金流 [3] - 与此同时,被告人却传播了关于库存水平、价格和市场份额稳定的虚假和误导性信息 [3] - 当真实情况被披露时,投资者遭受了损失 [3] 根据相关目录分别进行总结 诉讼背景 - Rosen Law Firm代表2024年2月15日至7月24日期间购买Stellantis证券的投资者提起集体诉讼 [1] - 投资者有望在不支付任何费用的情况下获得赔偿,这是通过或有费用安排实现的 [1] - 投资者需要在2024年10月15日之前提出加入集体诉讼的申请 [1] 原告律师事务所介绍 - Rosen Law Firm是一家专注于证券集体诉讼和股东衍生诉讼的全球投资者权益律师事务所 [2] - 该所在证券集体诉讼领域拥有丰富的成功经验,并在多个权威排名中名列前茅 [2] - 该所的律师多次获得Lawdragon和Super Lawyers等权威机构的认可 [2]